BioCentury
ARTICLE | Company News

Management tracks

May 7, 2015 2:30 AM UTC

H. Lundbeck A/S (CSE:LUN) named Kare Schultz president and CEO, effective May 20. Schultz was president and COO at Novo Nordisk A/S (CSE:NVO; NYSE:NVO). He replaces Ulf Wiinberg, who resigned in November 2014.

Endocrine play Versartis Inc. (NASDAQ:VSAR) named Jay Shepard president and CEO. Shepard, a former executive partner at Sofinnova Ventures, joined Versartis as executive chairman in 2014. Former CEO Jeffrey Cleland will remain as senior scientific advisor. ...